Pharmaceutical Output Fell by 4% Compared With the Previous Quarter. Sept 10 (Reuters) - A Slight Recovery in the German Chemicals Sector Lost Momentum in the Second Quarter, a Report by the VCI Industry Body Said on Tuesday, as Both Domestic and Foreign Orders Slowed in the April-June Period, Especially in the Pharmaceutical Branch.
9月10日（路透社）- 德國化學品行業出現了輕微復甦，但在第二季度失去了動力，VCI工業機構週二表示，4月至6月期間，國內外訂單均出現放緩，特別是在藥品行業。
"the Global Economy Has Not Picked up Speed as Hoped," VCI's Managing Director Wolfgang Grosse Entrup Said in a Press Release, Adding That Germany's Structural Problems, Such as High Production Costs, Red Tape and Labour Shortages, Remain Unresolved.
「全球經濟並沒有如人們所希望的那樣加速增長，」 VCI董事長沃爾夫岡·格羅斯·恩特魯普在新聞發佈會上表示，並補充說，德國的結構性問題，如高生產成本、繁文縟節和勞動力短缺，仍未得到解決。
Overall Production in the Chemicals Sector Including Pharmaceuticals Added Only 0.8% Quarter-on-Quarter, Slowing Down Drastically From the January-March Quarterly Increase of 5%.
包括藥品在內的化學品行業的整體產量季度環比僅增長了0.8%，較一季度（1-3月）的增長率明顯放緩。 增長 爲5%。
Germany's Chemicals Industry Suffered Heavily Throughout 2023 Due to High Production Costs and Weak Demand Amidst High Inflation. Europe's Largest Chemicals Producer Started Showing the First Signs of Recovery in the First Quarter of This Year, Which Are Now Fading Away.
德國化學工業在2023年全年飽受高生產成本和高通脹中需求疲軟的影響。歐洲最大的化學品生產商在今年第一季度開始顯露出復甦的初現，但這一跡象現在正在逐漸消失。
Pharmaceutical Output Fell by 4% Compared With the Previous Quarter.
與上一季度相比，藥品產量下降了4%。
On the Annual Comparison, Overall Production Was up 3.7%, or 8.4% When Pharmaceuticals Were Excluded, but Revenue Fell by 0.6% Compared With the Same Period Last Year.
按年度比較，總產量增長了3.7%，或者當不包括藥品時，增長了8.4%，但與去年同期相比，營業收入下降了0.6%。
Still, the Industry Maintained Its Annual Guidance for Production Volumes Including Pharmaceuticals to Grow by 3.5% and Industrial Sales by 1.5%.
然而，行業仍保持了年度指導，包括藥品在內的產量預計增長3.5%，工業銷售增長1.5%。
(Reporting by Andrey Sychev
Editing by Miranda Murray)
(作者 安德烈·西切夫 編輯 米蘭達·默裏)
安德烈.西切夫@湯森路透.com
((安德烈.西切夫@湯森路透.com))